Schonfeld Strategic Advisors LLC Ascendis Pharma A/S Transaction History

Schonfeld Strategic Advisors LLC

$15.4 Billion
Q4 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 138,593 shares of ASND stock, worth $21.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

138,593

Previous 228,525 39.35%

Holding current value

$21.7 Million

Previous $34.1 Million 44.09%

% of portfolio

0.12%

Previous 0.25%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$122.0 - $146.6 $11 Million - $13.2 Million	-89,932 Reduced 39.35%	138,593 $19.1 Million
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $14.7 Million - $20 Million	130,384 Added 132.85%	228,525 $34.1 Million
Q2 2024 Aug 14, 2024	SELL	$121.07 - $153.67 $467,209 - $593,012	-3,859 Reduced 3.78%	98,141 $13.4 Million
Q1 2024 May 15, 2024	SELL	$123.45 - $159.4 $2.83 Million - $3.65 Million	-22,901 Reduced 18.34%	102,000 $15.4 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $7.4 Million - $11 Million	86,001 Added 221.08%	124,901 $15.7 Million
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $666,050 - $800,569	7,700 Added 24.68%	38,900 $3.64 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $720,587 - $1.01 Million	10,300 Added 49.28%	31,200 $2.78 Million
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $4.93 Million - $5.95 Million	-46,958 Reduced 69.2%	20,900 $2.24 Million
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $5.21 Million - $6.91 Million	52,358 Added 337.79%	67,858 $8.29 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $1.3 Million - $1.71 Million	15,500 New	15,500 $1.6 Million
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $1.31 Million - $1.74 Million	-12,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $1.63 Million - $2.17 Million	12,800 New	12,800 $1.72 Million
Q3 2021 Nov 16, 2021	SELL	$112.67 - $176.92 $1.57 Million - $2.46 Million	-13,900 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$121.62 - $145.29 $656,748 - $784,566	-5,400 Reduced 27.98%	13,900 $1.83 Million
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $1.36 Million - $1.63 Million	11,200 Added 138.27%	19,300 $2.54 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $2.06 Million - $2.86 Million	-16,520 Reduced 67.1%	8,100 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $498,203 - $602,194	-3,295 Reduced 11.8%	24,620 $4.11 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $1.8 Million - $2.07 Million	13,415 Added 92.52%	27,915 $4,000
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $1.61 Million - $2.26 Million	14,500 New	14,500 $2.14 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $1.11 Million - $1.65 Million	-11,400 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$91.45 - $139.12 $2.6 Million - $3.95 Million	-28,400 Reduced 71.36%	11,400 $1.59 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $4.95 Million - $6.15 Million	-51,700 Reduced 56.5%	39,800 $3.83 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $9.95 Million - $12.3 Million	-92,900 Reduced 50.38%	91,500 $10.5 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $11.5 Million - $24 Million	184,400 New	184,400 $21.7 Million
Q3 2018 Nov 14, 2018	SELL	$63.77 - $76.28 $956,550 - $1.14 Million	-15,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $878,250 - $1.11 Million	15,000 New	15,000 $997,000
Q4 2017 Feb 14, 2018	SELL	$31.98 - $40.38 $312,220 - $394,229	-9,763 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$26.89 - $37.1 $262,527 - $362,207	9,763	9,763 $354,000

Others Institutions Holding ASND

# of Institutions

236

Shares Held

60.2M

Call Options Held

80.3K

Put Options Held

216K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.74B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Ascendis Pharma A/S Transaction History